VEGFA and pulmonary fibrosis: Furthermore, Chaudhary et al. [109] demonstrated that BIBF 1000, a novel tyrosine kinase inhibitor of PDGF, FGF and VEGF, attenuated BLM-induced pulmonary fibrosis in rats, as measured by a reduction in collagen deposition and the inhibition of pro-fibrotic gene expression.